---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-184752"
form_type: "8-K"
ticker: "COYA"
cik: "0001835022"
company_name: "Coya Therapeutics, Inc."
filed_at: "2023-07-10T23:59:59+00:00"
generated_at: "2026-06-13T10:39:50.539096+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Coya Therapeutics: Dr. Adrian Hepner resigns as President/CMO, replaced by Dr. Fred Grossman

## Summary
- Dr. Fred Grossman appointed President and CMO effective July 17, 2023, succeeding Dr. Adrian Hepner who resigned.
- Base salary $450,000/year; annual bonus target 40% of base salary based on company-set objectives.
- Two option grants each for 74,069 shares (first on start date, second Jan 2024); 24,689 shares vest after 1 year, remainder over 24 months.
- Employment agreement initial term of 2 years, auto-renews annually unless either party gives 30-day notice.

## SEC filing metadata
- accession: 0001193125-23-184752
- form_type: 8-K
- ticker: COYA
- cik: 0001835022
- company_name: Coya Therapeutics, Inc.
- filed_at: 2023-07-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1835022/000119312523184752/0001193125-23-184752-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1835022/000119312523184752/d530395d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-184752
- JSON: https://secwatch.observer/filing/0001193125-23-184752.json
- Plain text: https://secwatch.observer/filing/0001193125-23-184752.txt

## Key facts
- Executive change
  Dr. Fred Grossman was appointed as President and Chief Medical Officer at Coya Therapeutics, Inc..
  - Action: appointed
  - Role: President and Chief Medical Officer
  source text: On July 3, 2023, the Company appointed Dr. Fred Grossman President and Chief Medical Officer, effective July 17, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1835022/000119312523184752/0001193125-23-184752-index.htm
- Executive change
  Dr. Adrian Hepner resigned as President and Chief Medical Officer at Coya Therapeutics, Inc..
  - Action: resigned
  - Role: President and Chief Medical Officer
  source text: Dr. Adrian Hepner, the current President and Chief Medical Officer of Coya Therapeutics, Inc. (the “Company”), has informed the Company that he will resign from his position effective July 17, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1835022/000119312523184752/0001193125-23-184752-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.